Systemic sclerosis (scleroderma) and Ill-defined disorder

Summary:

Ill-defined disorder is found among people with Systemic sclerosis (scleroderma), especially for people who are male, 50-59 old.

The study analyzes which people have Ill-defined disorder with Systemic sclerosis (scleroderma). It is created by eHealthMe based on reports of 43 people who have Systemic sclerosis (scleroderma) from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Systemic sclerosis (scleroderma)?

Systemic sclerosis (scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin) is found to be associated with 493 drugs and 857 conditions by eHealthMe. Check the latest studies of Systemic sclerosis (scleroderma).

What is Ill-defined disorder?

Ill-defined disorder is found to be associated with 1,461 drugs and 1,258 conditions by eHealthMe. Check the latest studies of Ill-defined disorder.



On Aug, 03, 2026

43 people who have Systemic Sclerosis (Scleroderma) and Ill-Defined Disorder are studied.

Would you have Ill-defined disorder when you have Systemic sclerosis (scleroderma)?

Gender of people who have Systemic Sclerosis (Scleroderma) and experienced Ill-Defined Disorder *:

  • female: 42.31 %
  • male: 57.69 %

Age of people who have Systemic Sclerosis (Scleroderma) and experienced Ill-Defined Disorder *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 4.35 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 65.22 %
  • 60+: 30.43 %

Common co-existing conditions for these people *:

  1. Interstitial Lung Disease: 22 people, 51.16%
  2. Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 20 people, 46.51%
  3. High Blood Pressure: 8 people, 18.60%
  4. Myositis (inflammation of the muscles): 7 people, 16.28%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 13.95%
  6. Heart Attack: 5 people, 11.63%
  7. Hyperchlorhydria (gastric acid levels are higher in stomach): 5 people, 11.63%
  8. High Blood Cholesterol: 5 people, 11.63%
  9. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 5 people, 11.63%
  10. Helicobacter Infection (helicobacter pylori (h. pylori) infects stomach): 5 people, 11.63%

Common drugs taken by these people *:

  1. Benadryl: 15 people, 34.88%
  2. Trental: 15 people, 34.88%
  3. Dexilant: 15 people, 34.88%
  4. Diflucan: 15 people, 34.88%
  5. Septra: 15 people, 34.88%
  6. Nasonex: 15 people, 34.88%
  7. Prozac: 15 people, 34.88%
  8. Prednisone: 14 people, 32.56%
  9. Sulfatrim: 13 people, 30.23%
  10. Methylprednisolone: 11 people, 25.58%

Common symptoms for these people *:

  1. Oxygen Saturation Decreased: 29 people, 67.44%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 24 people, 55.81%
  3. Dyspnea (difficult or laboured breathing): 22 people, 51.16%
  4. Nausea And Vomiting: 22 people, 51.16%
  5. Rales (an abnormal respiratory sound characterized by fine crackles): 19 people, 44.19%
  6. Pneumonia: 18 people, 41.86%
  7. Blood Pressure Systolic Increased: 18 people, 41.86%
  8. Cough: 18 people, 41.86%
  9. Nausea (feeling of having an urge to vomit): 17 people, 39.53%
  10. High Blood Pressure: 16 people, 37.21%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Ill-defined disorder?

- Check whether Ill-defined disorder is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Ill-defined disorder:

All the conditions that are associated with Ill-defined disorder:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Ill-defined disorder and Systemic sclerosis (scleroderma), and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: